Use of generic or brand names in prescriptions

[Guest guest]

Copied as fair use from E Drug, post from Shazia, our member.

Vijay Thawani

Groupie

----------------------------------------------------------

E-DRUG: Use of generic or brand names in prescriptions (6)

-----------------------------------------------

Generic medicine policies of the developing countries reflects

disparity in terms of effective execution

Although a tailor-made regulatory framework in some developing

countries to galvanize the registration procedure for generics along

with a minimal amount of registration fee is evident, the flunking

of any generic medicine policy is in fact interplay of many

composite factors.

Discredited status of generics in the eyes of prescriber makes them

as scarce as hen's teeth in prescription. The image of generic drugs

whether in the eyes of prescriber or dispenser is built on negative

preconceived notions about their efficacy and safety thus owing to

deficient or expensive infrastructure facilities which demonstrates

their quality.

Even in certain instances consumer being aware of generic medicines

preferably opts for brand drugs considering them to be more potent,

safe and efficacious as compared to their generic counterparts.

In developing countries with changing dynamics of economies

consumers although procuring medicines on sheer out-of-pocket basis

are not deterred to pick out high-priced innovator brands.

Generic penetration varies in the developing world and the sale of

generics are growing in all the major markets but the proper

domestic availability of quality generics and quality use is still a

question mark.

The National Health Policy of India (2002) emphasizes the need for

the use of generic drugs as a prerequisite for cost-effective public

health care but the availability in the public sector is still not

proper.

Innovator products were priced 90% higher than the lowest price

generics in Pakistan. The National Drug Policy has failed to achieve

its public health objectives; although clearly highlighting proper

use of generics. In the past generics have been knocked down due to

perceived flaws such as quality, safety and efficacy.

In developing countries just and upright health system can only be

acquired through groundbreaking measures. Brazil is one such

example. Brazil exhibits tenacious commitment to public health

issues. Brazilians successfully retained this steadfast fixity of

purpose of defending their health system despite all odds. In 1999

Brazil instituted its generic medicine policy and therefore generics

instantaneously gripped the Brazilian pharmaceutical market.

Promulgation of the legislation and sensitization of the public by

means of mass media coverage as well as active participation of the

government were underlying components of its success. Thus

Brazilians purchase medicines at more affordable prices.

Why can't Brazil be a model in terms of access and affordability of

medicines in Indo-Pakistan subcontinent?

Shazia Jamshed

PhD Scholar

Social and Administrative Pharmacy

School of Pharmaceutical Sciences

Universiti Sains Malaysia

Penang

Malaysia

shazia jamshed <shazia_12@...>

_______________________________________________

Post message: e-drug@...

Subscribe: e-drug-join@...

Unsubscribe: e-drug-leave@...

Help: e-drug-owner@...

Info & archives: http://list.healthnet.org/mailman/listinfo/e-drug

[Guest guest]

Hi NetRUMians,

Please read the following news.

" Beginning (January 1) doctors, both in the private

and public sectors, will have to prescribe drugs under

their generic names and explain to patients the

advantages of prescribing drugs under generic names

instead of trade names. This regulation is being

implemented under the Private Medical Ordinance Act

and Government Medical Ordinance Act.

Healthcare Minister(Sri Lanka) Nimal Siripala de Silva

told 'The Island' that the rationale for this

initiative was that multinational pharmaceutical

companies had been exploiting patients and inexpensive

drugs were being sold at exorbitant prices under trade

names. "

Comments from members are invited.

Dr. Bharat Gajjar.

--- Vijay <drvijaythawani@...> wrote:

> Copied as fair use from E Drug, post from Shazia,

> our member.

> Vijay Thawani

> Groupie

>

----------------------------------------------------------

>

> E-DRUG: Use of generic or brand names in

> prescriptions (6)

> -----------------------------------------------

>

> Generic medicine policies of the developing

> countries reflects

> disparity in terms of effective execution

>

> Although a tailor-made regulatory framework in some

> developing

> countries to galvanize the registration procedure

> for generics along

> with a minimal amount of registration fee is

> evident, the flunking

> of any generic medicine policy is in fact interplay

> of many

> composite factors.

>

> Discredited status of generics in the eyes of

> prescriber makes them

> as scarce as hen's teeth in prescription. The image

> of generic drugs

> whether in the eyes of prescriber or dispenser is

> built on negative

> preconceived notions about their efficacy and safety

> thus owing to

> deficient or expensive infrastructure facilities

> which demonstrates

> their quality.

>

> Even in certain instances consumer being aware of

> generic medicines

> preferably opts for brand drugs considering them to

> be more potent,

> safe and efficacious as compared to their generic

> counterparts.

>

> In developing countries with changing dynamics of

> economies

> consumers although procuring medicines on sheer

> out-of-pocket basis

> are not deterred to pick out high-priced innovator

> brands.

>

> Generic penetration varies in the developing world

> and the sale of

> generics are growing in all the major markets but

> the proper

> domestic availability of quality generics and

> quality use is still a

> question mark.

>

> The National Health Policy of India (2002)

> emphasizes the need for

> the use of generic drugs as a prerequisite for

> cost-effective public

> health care but the availability in the public

> sector is still not

> proper.

>

> Innovator products were priced 90% higher than the

> lowest price

> generics in Pakistan. The National Drug Policy has

> failed to achieve

> its public health objectives; although clearly

> highlighting proper

> use of generics. In the past generics have been

> knocked down due to

> perceived flaws such as quality, safety and

> efficacy.

>

> In developing countries just and upright health

> system can only be

> acquired through groundbreaking measures. Brazil is

> one such

> example. Brazil exhibits tenacious commitment to

> public health

> issues. Brazilians successfully retained this

> steadfast fixity of

> purpose of defending their health system despite all

> odds. In 1999

> Brazil instituted its generic medicine policy and

> therefore generics

> instantaneously gripped the Brazilian pharmaceutical

> market.

> Promulgation of the legislation and sensitization of

> the public by

> means of mass media coverage as well as active

> participation of the

> government were underlying components of its

> success. Thus

> Brazilians purchase medicines at more affordable

> prices.

>

> Why can't Brazil be a model in terms of access and

> affordability of

> medicines in Indo-Pakistan subcontinent?

>

> Shazia Jamshed

> PhD Scholar

> Social and Administrative Pharmacy

> School of Pharmaceutical Sciences

> Universiti Sains Malaysia

> Penang

> Malaysia

> shazia jamshed <shazia_12@...>

>

> _______________________________________________

> Post message: e-drug@...

> Subscribe: e-drug-join@...

> Unsubscribe: e-drug-leave@...

> Help: e-drug-owner@...

> Info & archives:

> http://list.healthnet.org/mailman/listinfo/e-drug

>

>

>

>

>

>

________________________________________________________________________________\

____

Looking for last minute shopping deals?

Find them fast with Search.

http://tools.search./newsearch/category.php?category=shopping

[Guest guest]

Hi, I wish the same was for India AnupamaBharat Gajjar <gajjarbm@...> wrote: Hi NetRUMians,Please read the following news."Beginning (January 1) doctors, both in the privateand public sectors, will have to prescribe drugs undertheir generic names and explain to patients theadvantages of prescribing drugs under generic namesinstead of trade names. This regulation is beingimplemented under the Private Medical Ordinance Actand Government Medical Ordinance Act.

Healthcare Minister(Sri Lanka) Nimal Siripala de Silvatold 'The Island' that the rationale for thisinitiative was that multinational pharmaceuticalcompanies had been exploiting patients and inexpensivedrugs were being sold at exorbitant prices under tradenames."Comments from members are invited.Dr. Bharat Gajjar.--- Vijay <drvijaythawani (DOT) co.in> wrote:> Copied as fair use from E Drug, post from Shazia,> our member.> Vijay Thawani> Groupie>----------------------------------------------------------> > E-DRUG: Use of generic or brand names in> prescriptions (6)> -----------------------------------------------> > Generic medicine policies of the developing> countries reflects > disparity in terms of effective

execution > > Although a tailor-made regulatory framework in some> developing > countries to galvanize the registration procedure> for generics along > with a minimal amount of registration fee is> evident, the flunking > of any generic medicine policy is in fact interplay> of many > composite factors.> > Discredited status of generics in the eyes of> prescriber makes them > as scarce as hen's teeth in prescription. The image> of generic drugs > whether in the eyes of prescriber or dispenser is> built on negative > preconceived notions about their efficacy and safety> thus owing to > deficient or expensive infrastructure facilities> which demonstrates > their quality. > > Even in certain instances consumer being aware of> generic medicines > preferably opts for brand drugs considering them

to> be more potent, > safe and efficacious as compared to their generic> counterparts. > > In developing countries with changing dynamics of> economies > consumers although procuring medicines on sheer> out-of-pocket basis > are not deterred to pick out high-priced innovator> brands.> > Generic penetration varies in the developing world> and the sale of > generics are growing in all the major markets but> the proper > domestic availability of quality generics and> quality use is still a > question mark. > > The National Health Policy of India (2002)> emphasizes the need for > the use of generic drugs as a prerequisite for> cost-effective public > health care but the availability in the public> sector is still not > proper.> > Innovator products were priced 90% higher than

the> lowest price > generics in Pakistan. The National Drug Policy has> failed to achieve > its public health objectives; although clearly> highlighting proper > use of generics. In the past generics have been> knocked down due to > perceived flaws such as quality, safety and> efficacy. > > In developing countries just and upright health> system can only be > acquired through groundbreaking measures. Brazil is> one such > example. Brazil exhibits tenacious commitment to> public health > issues. Brazilians successfully retained this> steadfast fixity of > purpose of defending their health system despite all> odds. In 1999 > Brazil instituted its generic medicine policy and> therefore generics > instantaneously gripped the Brazilian pharmaceutical> market. > Promulgation of the legislation and

sensitization of> the public by > means of mass media coverage as well as active> participation of the > government were underlying components of its> success. Thus > Brazilians purchase medicines at more affordable> prices.> > Why can't Brazil be a model in terms of access and> affordability of > medicines in Indo-Pakistan subcontinent?> > Shazia Jamshed> PhD Scholar> Social and Administrative Pharmacy> School of Pharmaceutical Sciences> Universiti Sains Malaysia> Penang > Malaysia> shazia jamshed <shazia_12 >> > _______________________________________________> Post message: e-drughealthnet (DOT) org> Subscribe: e-drug-joinhealthnet (DOT) org> Unsubscribe: e-drug-leavehealthnet (DOT) org> Help: e-drug-ownerhealthnet (DOT) org> Info & archives:> http://list.healthnet.org/mailman/listinfo/e-drug> > > > > > __________________________________________________________Looking for last minute shopping deals? Find them fast with Search. http://tools.search./newsearch/category.php?category=shopping

Share files, take polls, and discuss your passions - all under one roof. Click here.

[Guest guest]

Detail of the news:

Srilanka - Prescribing generic drugs a must from today

Updated - 1/1/2008 - dailynews.lk.

Prescribing generic drugs a must from today

The Healthcare and Nutrition Ministry has decided to

ban the issuing of prescriptions in the drugs’ trade

name and made it compulsory to issue drugs prescribed

by doctors in Government and private hospitals in the

drugs’ generic names from today.

Healthcare and Nutrition Minister Nimal Siripala de

Silva said a circular in this regard has been issued

to all Government hospitals.

" But doctors in private hospitals must explain to

patients about the benefits of issuing the drug

prescribed under the generic name. From the beginning,

multi-national companies earned more money selling

drugs at expensive prices.

" If doctors do not follow Ministry decisions, they are

violating the Private Medical Ordinance, " Minister de

Silva said.

The Minister said those who violate the Private

Medical Ordinance will be punished. De Silva speaking

at the opening of the Rajjya Osu Sela at the

Karapitiya Teaching Hospital yesterday, said the State

Pharmaceuticals Corporation has taken steps to

establish several Rajjya Osu Sal at Government

Hospitals to support the launch of the drugs policy of

late Professor Senaka Bibile. Under this programme the

second Rajjya Osu Sela was opened at the Karapitiya

Teaching Hospital.

De Silva said the Health Ministry’s aim is to give a

quality health service to the people.

--- Bharat Gajjar <gajjarbm@...> wrote:

> Hi NetRUMians,

> Please read the following news.

>

> " Beginning (January 1) doctors, both in the private

> and public sectors, will have to prescribe drugs

> under

> their generic names and explain to patients the

> advantages of prescribing drugs under generic names

> instead of trade names. This regulation is being

> implemented under the Private Medical Ordinance Act

> and Government Medical Ordinance Act.

> Healthcare Minister(Sri Lanka) Nimal Siripala de

> Silva

> told 'The Island' that the rationale for this

> initiative was that multinational pharmaceutical

> companies had been exploiting patients and

> inexpensive

> drugs were being sold at exorbitant prices under

> trade

> names. "

>

> Comments from members are invited.

> Dr. Bharat Gajjar.

>

> --- Vijay <drvijaythawani@...> wrote:

>

> > Copied as fair use from E Drug, post from Shazia,

> > our member.

> > Vijay Thawani

> > Groupie

> >

>

----------------------------------------------------------

> >

> > E-DRUG: Use of generic or brand names in

> > prescriptions (6)

> > -----------------------------------------------

> >

> > Generic medicine policies of the developing

> > countries reflects

> > disparity in terms of effective execution

> >

> > Although a tailor-made regulatory framework in

> some

> > developing

> > countries to galvanize the registration procedure

> > for generics along

> > with a minimal amount of registration fee is

> > evident, the flunking

> > of any generic medicine policy is in fact

> interplay

> > of many

> > composite factors.

> >

> > Discredited status of generics in the eyes of

> > prescriber makes them

> > as scarce as hen's teeth in prescription. The

> image

> > of generic drugs

> > whether in the eyes of prescriber or dispenser is

> > built on negative

> > preconceived notions about their efficacy and

> safety

> > thus owing to

> > deficient or expensive infrastructure facilities

> > which demonstrates

> > their quality.

> >

> > Even in certain instances consumer being aware of

> > generic medicines

> > preferably opts for brand drugs considering them

> to

> > be more potent,

> > safe and efficacious as compared to their generic

> > counterparts.

> >

> > In developing countries with changing dynamics of

> > economies

> > consumers although procuring medicines on sheer

> > out-of-pocket basis

> > are not deterred to pick out high-priced innovator

> > brands.

> >

> > Generic penetration varies in the developing

> world

> > and the sale of

> > generics are growing in all the major markets but

> > the proper

> > domestic availability of quality generics and

> > quality use is still a

> > question mark.

> >

> > The National Health Policy of India (2002)

> > emphasizes the need for

> > the use of generic drugs as a prerequisite for

> > cost-effective public

> > health care but the availability in the public

> > sector is still not

> > proper.

> >

> > Innovator products were priced 90% higher than

> the

> > lowest price

> > generics in Pakistan. The National Drug Policy has

> > failed to achieve

> > its public health objectives; although clearly

> > highlighting proper

> > use of generics. In the past generics have been

> > knocked down due to

> > perceived flaws such as quality, safety and

> > efficacy.

> >

> > In developing countries just and upright health

> > system can only be

> > acquired through groundbreaking measures. Brazil

> is

> > one such

> > example. Brazil exhibits tenacious commitment to

> > public health

> > issues. Brazilians successfully retained this

> > steadfast fixity of

> > purpose of defending their health system despite

> all

> > odds. In 1999

> > Brazil instituted its generic medicine policy and

> > therefore generics

> > instantaneously gripped the Brazilian

> pharmaceutical

> > market.

> > Promulgation of the legislation and sensitization

> of

> > the public by

> > means of mass media coverage as well as active

> > participation of the

> > government were underlying components of its

> > success. Thus

> > Brazilians purchase medicines at more affordable

> > prices.

> >

> > Why can't Brazil be a model in terms of access

> and

> > affordability of

> > medicines in Indo-Pakistan subcontinent?

> >

> > Shazia Jamshed

> > PhD Scholar

> > Social and Administrative Pharmacy

> > School of Pharmaceutical Sciences

> > Universiti Sains Malaysia

> > Penang

> > Malaysia

> > shazia jamshed <shazia_12@...>

> >

> > _______________________________________________

> > Post message: e-drug@...

> > Subscribe: e-drug-join@...

> > Unsubscribe: e-drug-leave@...

> > Help: e-drug-owner@...

> > Info & archives:

> > http://list.healthnet.org/mailman/listinfo/e-drug

> >

> >

> >

> >

> >

> >

>

>

>

>

>

________________________________________________________________________________\

____

> Looking for last minute shopping deals?

> Find them fast with Search.

>

http://tools.search./newsearch/category.php?category=shopping

>

________________________________________________________________________________\

____

Looking for last minute shopping deals?

Find them fast with Search.

http://tools.search./newsearch/category.php?category=shopping

[Guest guest]

The HATHI Committee recommendations are commendable, but like all valuable reports which would end up hurting profiteering of the industry at the cost of the public, are conveniently suppressed.

The Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002, in Chapter 1, Clause 1.5 says : Use of Generic names of Drugs : Every physician should, as far as possible, prescribe drugs with generic names and he/she shall ensure that there is a rational prescription and use of drugs.

Marketing pressures are too heavy to overcome today's trend of prescribing by brand names in the country today. But, also being fair to prescribers, following could be the possible reasons, why it could be safer to prescribe by Brand names :

1) Prescribing by generic names gives the freedom to the pharmacy to decide on which brand, or a generic of which company to dispense. Here too there are factors of large schemes and discounts, which could very well tempt the pharmacy to end up dispensing which may not be effective.

2) In India, we do not have a system of approving drugs only after bioavailability and bioequivalence tests, unlike most other countries (bioequivalence to a standard, approved, exiting brand has to be first established/proved to get permission to market a generic). So, in India, as long as the production batches are shown to pass the stipulated tests (friability, content, disintegration, for some drugs dissolution), the drugs are considered as "of appropriate quality". For majority of the drugs in the market today, bioavailability tests have never been done (costs of course to do a bioavailability test for a single drug is considered quite prohibitive by most companies). A bioequivalence proof should actually be mandatory, at least for those drugs which have narrow therapeutic index, low solubility, etc.

3) Besides this, there are plenty of brands in the market which are tested at random by the FDA and found to be sub-standard. Whilst such lists do include products of well known reputed companies at times, the frequencies are lower.

4) "Generics", or the "branded generics" in our country have no significance to the consumer, because the MRP of these is most of the times almost the same as that of the regular brands, and at times "higher" too. The profits are shared by the company, and the distribution chain in varying percentages. WHilst, by true definition, in all other parts of the world, "Generics" are many many times "cheaper" than the Brand. Except perhaps India.

5) In India, by law, "Brand substitution" is illegal/not allowed. So, even if the consumer wants to buy a cheaper brand even though the doctor prescribes a costly one, strictly speaking, by law cannot happen, because the pharmacy is not allowed to dispense another brand. That it can happen, and no one objects/will object today is a different story.

Therefore, all such factors in INDIA favour that the doctor prescribes by a brand, till such matters are sorted out, and "every" drug in our country becomes of an "assured" quality. Of course, this does not justify prescribing "costly" brands.

I would recommend the following for starters :

1) The doctor writes the generic name for every drug, and in bracket writes the brand name or the name of the company (To inculcate the habit of writing by generics).

2) The doctor chooses a reputed company, but also ensures that the cost is "reasonable", and amongst the lowest.

There will be varied opinions to the above, and we should have a "healthy" debate on this.

Raj Vaidya

COmmunity Pharmacist

Panaji - Goa

On 1/20/08, Bharat Gajjar <gajjarbm@...> wrote:

Detail of the news:Srilanka - Prescribing generic drugs a must from todayUpdated - 1/1/2008 - dailynews.lk

..Prescribing generic drugs a must from today The Healthcare and Nutrition Ministry has decided toban the issuing of prescriptions in the drugs' tradename and made it compulsory to issue drugs prescribed

by doctors in Government and private hospitals in thedrugs' generic names from today. Healthcare and Nutrition Minister Nimal Siripala deSilva said a circular in this regard has been issuedto all Government hospitals. " But doctors in private hospitals must explain topatients about the benefits of issuing the drugprescribed under the generic name. From the beginning,multi-national companies earned more money selling

drugs at expensive prices. " If doctors do not follow Ministry decisions, they areviolating the Private Medical Ordinance, " Minister deSilva said. The Minister said those who violate the Private

Medical Ordinance will be punished. De Silva speakingat the opening of the Rajjya Osu Sela at theKarapitiya Teaching Hospital yesterday, said the StatePharmaceuticals Corporation has taken steps toestablish several Rajjya Osu Sal at Government

Hospitals to support the launch of the drugs policy oflate Professor Senaka Bibile. Under this programme thesecond Rajjya Osu Sela was opened at the KarapitiyaTeaching Hospital. De Silva said the Health Ministry's aim is to give a

quality health service to the people. --- Bharat Gajjar <gajjarbm@...> wrote:

> Hi NetRUMians,> Please read the following news.> > " Beginning (January 1) doctors, both in the private> and public sectors, will have to prescribe drugs> under> their generic names and explain to patients the

> advantages of prescribing drugs under generic names> instead of trade names. This regulation is being> implemented under the Private Medical Ordinance Act> and Government Medical Ordinance Act. > Healthcare Minister(Sri Lanka) Nimal Siripala de> Silva> told 'The Island' that the rationale for this> initiative was that multinational pharmaceutical> companies had been exploiting patients and

> inexpensive> drugs were being sold at exorbitant prices under> trade> names. " > > Comments from members are invited.> Dr. Bharat Gajjar.> > --- Vijay <

drvijaythawani@...> wrote:> > > Copied as fair use from E Drug, post from Shazia,

> > our member.> > Vijay Thawani> > Groupie> >>----------------------------------------------------------> > > > E-DRUG: Use of generic or brand names in

> > prescriptions (6)> > -----------------------------------------------> > > > Generic medicine policies of the developing> > countries reflects > > disparity in terms of effective execution > > > > Although a tailor-made regulatory framework in> some> > developing > > countries to galvanize the registration procedure> > for generics along > > with a minimal amount of registration fee is

> > evident, the flunking > > of any generic medicine policy is in fact> interplay> > of many > > composite factors.> > > > Discredited status of generics in the eyes of

> > prescriber makes them > > as scarce as hen's teeth in prescription. The> image> > of generic drugs > > whether in the eyes of prescriber or dispenser is> > built on negative > > preconceived notions about their efficacy and> safety> > thus owing to > > deficient or expensive infrastructure facilities> > which demonstrates > > their quality. > > > > Even in certain instances consumer being aware of> > generic medicines > > preferably opts for brand drugs considering them> to> > be more potent, > > safe and efficacious as compared to their generic

> > counterparts. > > > > In developing countries with changing dynamics of> > economies > > consumers although procuring medicines on sheer> > out-of-pocket basis > > are not deterred to pick out high-priced innovator> > brands.> > > > Generic penetration varies in the developing> world> > and the sale of > > generics are growing in all the major markets but

> > the proper > > domestic availability of quality generics and> > quality use is still a > > question mark. > > > > The National Health Policy of India (2002)

> > emphasizes the need for > > the use of generic drugs as a prerequisite for> > cost-effective public > > health care but the availability in the public> > sector is still not > > proper.> > > > Innovator products were priced 90% higher than> the> > lowest price > > generics in Pakistan. The National Drug Policy has> > failed to achieve > > its public health objectives; although clearly> > highlighting proper > > use of generics. In the past generics have been> > knocked down due to > > perceived flaws such as quality, safety and

> > efficacy. > > > > In developing countries just and upright health> > system can only be > > acquired through groundbreaking measures. Brazil> is> > one such > > example. Brazil exhibits tenacious commitment to> > public health > > issues. Brazilians successfully retained this> > steadfast fixity of > > purpose of defending their health system despite

> all> > odds. In 1999 > > Brazil instituted its generic medicine policy and> > therefore generics > > instantaneously gripped the Brazilian> pharmaceutical> > market. > > Promulgation of the legislation and sensitization> of> > the public by > > means of mass media coverage as well as active> > participation of the > > government were underlying components of its

> > success. Thus > > Brazilians purchase medicines at more affordable> > prices.> > > > Why can't Brazil be a model in terms of access> and> > affordability of > > medicines in Indo-Pakistan subcontinent?> > > > Shazia Jamshed> > PhD Scholar> > Social and Administrative Pharmacy> > School of Pharmaceutical Sciences> > Universiti Sains Malaysia

> > Penang > > Malaysia> > shazia jamshed <shazia_12@...>> > > > _______________________________________________> > Post message: e-drug@...

> > Subscribe: e-drug-join@...> > Unsubscribe:

e-drug-leave@...> > Help: e-drug-owner@...> > Info & archives:

> > http://list.healthnet.org/mailman/listinfo/e-drug> > > > > > > > > > > > > > > > >__________________________________________________________> Looking for last minute shopping deals? > Find them fast with Search. >http://tools.search./newsearch/category.php?category=shopping

> __________________________________________________________Looking for last minute shopping deals? Find them fast with Search.

http://tools.search./newsearch/category.php?category=shopping

[Guest guest]

Hi,

Thanks Raj for your views on the issue.

Even though IMC recommends generic prescription and rationality,it

has hardly done anything to promote it, except proposing.

I agree with you that the pharmaceutical companies dictate the

medicine policies to favour their financial health. These companies

ensure that nothing moves against them. The citizenry is naive and

does not realize the nexus, which finally hurts the patient interest.

For new formulations being introduced now BA/BE studies are

necessary but I agree that the previously existing formulations

these may not be in place. The DRA has to make these compulsory for

all.

I am supporter of brand substitution by pharmacists subject to :

- All pharmacies are manned by qualified pharmacists

- Law of the land permits such substitution

- There is generic availability in the pharmacies

- The generics have the quality

- The generics are cheaper than the branded products

Vijay

> > >

> > > > Copied as fair use from E Drug, post from Shazia,

> > > > our member.

> > > > Vijay Thawani

> > > > Groupie

> > > >

> > >

> > ----------------------------------------------------------

> > > >

> > > > E-DRUG: Use of generic or brand names in

> > > > prescriptions (6)

> > > > -----------------------------------------------

> > > >

> > > > Generic medicine policies of the developing

> > > > countries reflects

> > > > disparity in terms of effective execution

> > > >

> > > > Although a tailor-made regulatory framework in

> > > some

> > > > developing

> > > > countries to galvanize the registration procedure

> > > > for generics along

> > > > with a minimal amount of registration fee is

> > > > evident, the flunking

> > > > of any generic medicine policy is in fact

> > > interplay

> > > > of many

> > > > composite factors.

> > > >

> > > > Discredited status of generics in the eyes of

> > > > prescriber makes them

> > > > as scarce as hen's teeth in prescription. The

> > > image

> > > > of generic drugs

> > > > whether in the eyes of prescriber or dispenser is

> > > > built on negative

> > > > preconceived notions about their efficacy and

> > > safety

> > > > thus owing to

> > > > deficient or expensive infrastructure facilities

> > > > which demonstrates

> > > > their quality.

> > > >

> > > > Even in certain instances consumer being aware of

> > > > generic medicines

> > > > preferably opts for brand drugs considering them

> > > to

> > > > be more potent,

> > > > safe and efficacious as compared to their generic

> > > > counterparts.

> > > >

> > > > In developing countries with changing dynamics of

> > > > economies

> > > > consumers although procuring medicines on sheer

> > > > out-of-pocket basis

> > > > are not deterred to pick out high-priced innovator

> > > > brands.

> > > >

> > > > Generic penetration varies in the developing

> > > world

> > > > and the sale of

> > > > generics are growing in all the major markets but

> > > > the proper

> > > > domestic availability of quality generics and

> > > > quality use is still a

> > > > question mark.

> > > >

> > > > The National Health Policy of India (2002)

> > > > emphasizes the need for

> > > > the use of generic drugs as a prerequisite for

> > > > cost-effective public

> > > > health care but the availability in the public

> > > > sector is still not

> > > > proper.

> > > >

> > > > Innovator products were priced 90% higher than

> > > the

> > > > lowest price

> > > > generics in Pakistan. The National Drug Policy has

> > > > failed to achieve

> > > > its public health objectives; although clearly

> > > > highlighting proper

> > > > use of generics. In the past generics have been

> > > > knocked down due to

> > > > perceived flaws such as quality, safety and

> > > > efficacy.

> > > >

> > > > In developing countries just and upright health

> > > > system can only be

> > > > acquired through groundbreaking measures. Brazil

> > > is

> > > > one such

> > > > example. Brazil exhibits tenacious commitment to

> > > > public health

> > > > issues. Brazilians successfully retained this

> > > > steadfast fixity of

> > > > purpose of defending their health system despite

> > > all

> > > > odds. In 1999

> > > > Brazil instituted its generic medicine policy and

> > > > therefore generics

> > > > instantaneously gripped the Brazilian

> > > pharmaceutical

> > > > market.

> > > > Promulgation of the legislation and sensitization

> > > of

> > > > the public by

> > > > means of mass media coverage as well as active

> > > > participation of the

> > > > government were underlying components of its

> > > > success. Thus

> > > > Brazilians purchase medicines at more affordable

> > > > prices.

> > > >

> > > > Why can't Brazil be a model in terms of access

> > > and

> > > > affordability of

> > > > medicines in Indo-Pakistan subcontinent?

> > > >

> > > > Shazia Jamshed

> > > > PhD Scholar

> > > > Social and Administrative Pharmacy

> > > > School of Pharmaceutical Sciences

> > > > Universiti Sains Malaysia

> > > > Penang

> > > > Malaysia

> > > > shazia jamshed <shazia_12@... <shazia_12%40>>

> > > >

> > > > _______________________________________________

> > > > Post message: e-drug@... <e-drug%40healthnet.org>

> > > > Subscribe: e-drug-join@... <e-drug-join%40healthnet.org>

> > > > Unsubscribe: e-drug-leave@... <e-drug-leave%40healthnet.org>

> > > > Help: e-drug-owner@... <e-drug-owner%40healthnet.org>

> > > > Info & archives:

> > > > http://list.healthnet.org/mailman/listinfo/e-drug

> > > >

> > > >

> > > >

> > > >

> > > >

> > > >

> > >

> > >

> > >

> > >

> > >

> > __________________________________________________________

> > > Looking for last minute shopping deals?

> > > Find them fast with Search.

> > >

> > http://tools.search./newsearch/category.php?

category=shopping

> > >

> >

> > __________________________________________________________

> > Looking for last minute shopping deals?

> > Find them fast with Search.

> > http://tools.search./newsearch/category.php?

category=shopping

> >

> >

> >

>

[Guest guest]

Dear NETRUM members, Though i am not a regular and sincere member, i would like to share some of my personal views on the rationality in practicle. Since, many days, i am reading very good articles by eminent personalities in the field of pharmacology and others. I really enjoyed pharmacogenemics, antimocrobial usage and rational investigation approach. Being practitioner, i can tell you some my personal views on the same. this is an entire persoinal views. When i was studing pharmacology in second year, i taught , how drugs works, kinetics and dtynamicsI taught how to make LASOTIYAs...mixtures of various preparations.....and when i grew up , in third year i taught that what ever you learned in pharmacology is entirly theory and we the clinicians are dealing with the patients and not the disease describe in the text.

Why thre are so much controversiers eventhough the pharmacology and medicines are same?? After many years of thinking on this topic i can come to know little what are the roots of these controversies!! 1) what we studied was use less in terms of clinical setting. when ample no of pharmaceuticlas are making remedies for each illness then why should we waste our time behind so called lasotiyas........thanks to some working teachers , now these portion has been removed from curriculum. 2) we used to remember the pharmacokinetics, dynamics and uses of penicilline V.......the drug i never come across after second year!! why are we learning useless thigs? 3) we used to mug up the uses of various antibiotics.....but dont know which drug is to be administered in sore throat? cant we teach clinical pharmacology?? instead of drugs in

disease...cant we teach disease and their drugs? 4) Lack of interaction between pharmacologist and clinicians.........instead of talking what clinician should do and dont, cant we unit and make some protocol?? 5) when i started practice as consultant physician in village, i faced many problems....because.....THE CONCEPT OF THERE IS PILL FOR EVERY ILL by so called DOCTORS..BAMS, DHMS and waht not?? what to do in this circumstances?? i took three months to change senarios in the village by conducting many lectures and health promotional events.........who will do all these?? it is better to prescribe a pill than three months of perspiration!! 6) we derpend on western literature entirly. for example.........malaria eventhough, india harbours 40% of worlds malarial cases.....we have to follow the guidelines of WHO.....made by the persons who is not in the field and based on the

analysis of studies published in reputed journals because we believe in evidence based medicine!! none of the text describes.......what to do when you come across a patient who has clinical features resembling malaria but either you dnt have facility for PS examination or trained staff who can see parasite?? Many are dying of malaria, TB, and other infectious disease than CAD but everyone is behind statins!!! 7) education of patient is also a hurdle behind rational practice...........in that matter you have to be irrational to practice rationally!!. there are many still points........we will not discuss what are the problems beacuse we all know.......i will not suggest who should do and who dnt..........because everyone knows what he/she can do and contribute........so i will leave this upon everybody ............... Thanks, Dr. Viral Shah

Now you can chat without downloading messenger. Click here to know how.

[Guest guest]

there are ample no of mistakes in writing due to typing errors , so dont go through the english ......... "Dr.viral shah" <viralshah_rational@...> wrote: Dear NETRUM members, Though i am not a regular and sincere member, i would like to share some of my personal views on the rationality in practicle. Since, many days, i am reading very good articles by eminent personalities in the field of pharmacology and others. I really enjoyed pharmacogenemics,

antimocrobial usage and rational investigation approach. Being practitioner, i can tell you some my personal views on the same. this is an entire persoinal views. When i was studing pharmacology in second year, i taught , how drugs works, kinetics and dtynamicsI taught how to make LASOTIYAs...mixtures of various preparations.....and when i grew up , in third year i taught that what ever you learned in pharmacology is entirly theory and we the clinicians are dealing with the patients and not the disease describe in the text. Why thre are so much controversiers eventhough the pharmacology and medicines are same?? After many years of thinking on this topic i can come to know little what are the roots of these controversies!! 1) what we studied was use less in terms of clinical setting. when

ample no of pharmaceuticlas are making remedies for each illness then why should we waste our time behind so called lasotiyas........thanks to some working teachers , now these portion has been removed from curriculum. 2) we used to remember the pharmacokinetics, dynamics and uses of penicilline V.......the drug i never come across after second year!! why are we learning useless thigs? 3) we used to mug up the uses of various antibiotics.....but dont know which drug is to be administered in sore throat? cant we teach clinical pharmacology?? instead of drugs in disease...cant we teach disease and their drugs? 4) Lack of interaction between pharmacologist and clinicians.........instead of talking what clinician should do and dont, cant we unit and make some protocol?? 5) when i started practice as consultant physician in

village, i faced many problems....because.....THE CONCEPT OF THERE IS PILL FOR EVERY ILL by so called DOCTORS..BAMS, DHMS and waht not?? what to do in this circumstances?? i took three months to change senarios in the village by conducting many lectures and health promotional events.........who will do all these?? it is better to prescribe a pill than three months of perspiration!! 6) we derpend on western literature entirly. for example.........malaria eventhough, india harbours 40% of worlds malarial cases.....we have to follow the guidelines of WHO.....made by the persons who is not in the field and based on the analysis of studies published in reputed journals because we believe in evidence based medicine!! none of the text describes.......what to do when you come across a patient who has clinical features resembling malaria but either you dnt have

facility for PS examination or trained staff who can see parasite?? Many are dying of malaria, TB, and other infectious disease than CAD but everyone is behind statins!!! 7) education of patient is also a hurdle behind rational practice...........in that matter you have to be irrational to practice rationally!!. there are many still points........we will not discuss what are the problems beacuse we all know.......i will not suggest who should do and who dnt..........because everyone knows what he/she can do and contribute........so i will leave this upon everybody ............... Thanks, Dr. Viral Shah Now you can chat without downloading messenger. Click here to know how. Dr. Viral Shah MBBS, MD,FCCP Consultant Physician, 33, New People Society, Subhashanagar, Bhavnagar-364001. Mail: viralshah_rational@... drshahviral@...

Explore your hobbies and interests. Click here to begin.

[Guest guest]

Hi,

Hence it is advisable that one writes in word file, does a spell

check and then copy-paste on NetRUM.

Vijay

> Dear NETRUM members,

>

> Though i am not a regular and sincere member, i would like to

share some of my personal views on the rationality in practicle.

>

> Since, many days, i am reading very good articles by eminent

personalities in the field of pharmacology and others. I really

enjoyed pharmacogenemics, antimocrobial usage and rational

investigation approach.

>

> Being practitioner, i can tell you some my personal views on the

same. this is an entire persoinal views.

>

> When i was studing pharmacology in second year, i taught , how

drugs works, kinetics and dtynamicsI taught how to make

LASOTIYAs...mixtures of various preparations.....and when i grew

up , in third year i taught that what ever you learned in

pharmacology is entirly theory and we the clinicians are dealing

with the patients and not the disease describe in the text.

>

> Why thre are so much controversiers eventhough the pharmacology

and medicines are same??

>

> After many years of thinking on this topic i can come to know

little what are the roots of these controversies!!

>

> 1) what we studied was use less in terms of clinical setting.

when ample no of pharmaceuticlas are making remedies for each

illness then why should we waste our time behind so called

lasotiyas........thanks to some working teachers , now these portion

has been removed from curriculum.

>

> 2) we used to remember the pharmacokinetics, dynamics and uses

of penicilline V.......the drug i never come across after second

year!! why are we learning useless thigs?

>

> 3) we used to mug up the uses of various antibiotics.....but

dont know which drug is to be administered in sore throat? cant we

teach clinical pharmacology?? instead of drugs in disease...cant we

teach disease and their drugs?

>

> 4) Lack of interaction between pharmacologist and

clinicians.........instead of talking what clinician should do and

dont, cant we unit and make some protocol??

>

> 5) when i started practice as consultant physician in village, i

faced many problems....because.....THE CONCEPT OF THERE IS PILL FOR

EVERY ILL by so called DOCTORS..BAMS, DHMS and waht not?? what to do

in this circumstances?? i took three months to change senarios in

the village by conducting many lectures and health promotional

events.........who will do all these?? it is better to prescribe a

pill than three months of perspiration!!

>

> 6) we derpend on western literature entirly. for

example.........malaria eventhough, india harbours 40% of worlds

malarial cases.....we have to follow the guidelines of WHO.....made

by the persons who is not in the field and based on the analysis of

studies published in reputed journals because we believe in evidence

based medicine!!

>

> none of the text describes.......what to do when you come across

a patient

> who has clinical features resembling malaria but either you dnt

have facility for PS examination or trained staff who can see

parasite?? Many are dying of malaria, TB, and other infectious

disease than CAD but everyone is behind statins!!!

>

> 7) education of patient is also a hurdle behind rational

practice...........in that matter you have to be irrational to

practice rationally!!.

>

>

> there are many still points........we will not discuss what are

the problems beacuse we all know.......i will not suggest who should

do and who dnt..........because everyone knows what he/she can do

and contribute........so i will leave this upon

everybody ...............

>

>

> Thanks,

>

> Dr. Viral Shah

>

>

>

> ---------------------------------

> Now you can chat without downloading messenger. Click here to

know how.

>

>

>

>

> Dr. Viral Shah

> MBBS, MD,FCCP

> Consultant Physician,

> 33, New People Society,

> Subhashanagar,

> Bhavnagar-364001.

> Mail: viralshah_rational@...

> drshahviral@...

>

>

>

> ---------------------------------

> Explore your hobbies and interests. Click here to begin.

>

[Guest guest]

Dear Dr.Viral Shah,

Thank you for your experienced opinion on Pharmacology

teaching.

-Now most of the colleges have discontinued teaching

of dispensing pharmacy.Instead we are teaching

clinical pharmacy.

-We,at our college,P.S.Medical

College,Karamsad,Gujarat give more stress on clinical

pharmacology.Disease to drug concept is adopted by us

through integrated teaching.

-We,pharmacologists are constantly keeping in touch

with clinicians,undertaking projects based on patient

care with collaboration with them.

-We are teaching our students the principles of

essential drugs,Rational Drug Therapy,Adverse Drug

Reaction Monitoring etc. to make them efficient first

contact doctor.

With regards,

Dr.Bharat Gajjar.

Associate Professor,

Department of Pharmacology,

P.S.Medical College,

Karamsad,Gujarat.

--- " Dr.viral shah " <viralshah_rational@...>

wrote:

> Dear NETRUM members,

>

> Though i am not a regular and sincere member, i

> would like to share some of my personal views on the

> rationality in practicle.

>

> Since, many days, i am reading very good articles

> by eminent personalities in the field of

> pharmacology and others. I really enjoyed

> pharmacogenemics, antimocrobial usage and rational

> investigation approach.

>

> Being practitioner, i can tell you some my

> personal views on the same. this is an entire

> persoinal views.

>

> When i was studing pharmacology in second year, i

> taught , how drugs works, kinetics and dtynamicsI

> taught how to make LASOTIYAs...mixtures of various

> preparations.....and when i grew up , in third year

> i taught that what ever you learned in pharmacology

> is entirly theory and we the clinicians are dealing

> with the patients and not the disease describe in

> the text.

>

> Why thre are so much controversiers eventhough the

> pharmacology and medicines are same??

>

> After many years of thinking on this topic i can

> come to know little what are the roots of these

> controversies!!

>

> 1) what we studied was use less in terms of

> clinical setting. when ample no of pharmaceuticlas

> are making remedies for each illness then why should

> we waste our time behind so called

> lasotiyas........thanks to some working teachers ,

> now these portion has been removed from curriculum.

>

> 2) we used to remember the pharmacokinetics,

> dynamics and uses of penicilline V.......the drug i

> never come across after second year!! why are we

> learning useless thigs?

>

> 3) we used to mug up the uses of various

> antibiotics.....but dont know which drug is to be

> administered in sore throat? cant we teach clinical

> pharmacology?? instead of drugs in disease...cant

> we teach disease and their drugs?

>

> 4) Lack of interaction between pharmacologist and

> clinicians.........instead of talking what clinician

> should do and dont, cant we unit and make some

> protocol??

>

> 5) when i started practice as consultant physician

> in village, i faced many problems....because.....THE

> CONCEPT OF THERE IS PILL FOR EVERY ILL by so called

> DOCTORS..BAMS, DHMS and waht not?? what to do in

> this circumstances?? i took three months to change

> senarios in the village by conducting many lectures

> and health promotional events.........who will do

> all these?? it is better to prescribe a pill than

> three months of perspiration!!

>

> 6) we derpend on western literature entirly. for

> example.........malaria eventhough, india harbours

> 40% of worlds malarial cases.....we have to follow

> the guidelines of WHO.....made by the persons who is

> not in the field and based on the analysis of

> studies published in reputed journals because we

> believe in evidence based medicine!!

>

> none of the text describes.......what to do when

> you come across a patient

> who has clinical features resembling malaria but

> either you dnt have facility for PS examination or

> trained staff who can see parasite?? Many are dying

> of malaria, TB, and other infectious disease than

> CAD but everyone is behind statins!!!

>

> 7) education of patient is also a hurdle behind

> rational practice...........in that matter you have

> to be irrational to practice rationally!!.

>

>

> there are many still points........we will not

> discuss what are the problems beacuse we all

> know.......i will not suggest who should do and who

> dnt..........because everyone knows what he/she can

> do and contribute........so i will leave this upon

> everybody ...............

>

>

> Thanks,

>

> Dr. Viral Shah

>

>

>

>

> ---------------------------------

> Now you can chat without downloading messenger.

> Click here to know how.

________________________________________________________________________________\

____

Looking for last minute shopping deals?

Find them fast with Search.

http://tools.search./newsearch/category.php?category=shopping

[Guest guest]

Dear NetRUM colleagues, Morning As it is apparent to us, that all drugs have generic names. Whenever pharmaceutical companies first develop a new drug, so the pharmaceutical company gives the drug specific generic name and the company then gives the drug a brand-name as part of its marketing plan in order to give very simple and acceptable name to the drug. And mostly the generic name becomes accessible when the brand-name drug's copyright expires or changed. The same generic drug have different brand name, for example Benazepril (Lotensin) or Diclofenac Sodium (Voltaren) Regarding the cost-effectiveness of generic drugs, it’s less luxurious to make and vend generic drugs, so these savings are reflected in a lower price. Various brand-name drug costs are due to first development (Operation Cost) expenses. Producing a new drug and introducing it to local market requires a vast investment. When the initial costs are covered, new drug companies pay lower development (Operation) costs. Eventually the outcome will be a decrease in the price of generic drugs. Best BashaarBharat Gajjar <gajjarbm@...> wrote: Dear Dr.Viral Shah,Thank you for your experienced opinion on Pharmacologyteaching.-Now most of the colleges have discontinued teachingof dispensing pharmacy.Instead we are teachingclinical pharmacy.-We,at our college,P.S.MedicalCollege,Karamsad,Gujarat give more stress on clinicalpharmacology.Disease to drug concept is adopted by usthrough integrated teaching.-We,pharmacologists are constantly keeping in touchwith clinicians,undertaking projects based on patientcare with collaboration with them.-We are teaching our students the principles ofessential drugs,Rational Drug Therapy,Adverse DrugReaction Monitoring etc. to make them efficient firstcontact

doctor.With regards,Dr.Bharat Gajjar.Associate Professor,Department of Pharmacology,P.S.Medical College,Karamsad,Gujarat.--- "Dr.viral shah" <viralshah_rational (DOT) co.in>wrote:> Dear NETRUM members,> > Though i am not a regular and sincere member, i> would like to share some of my personal views on the> rationality in practicle.> > Since, many days, i am reading very good articles> by eminent personalities in the field of> pharmacology and others. I really enjoyed> pharmacogenemics, antimocrobial usage and rational> investigation approach.> > Being practitioner, i can tell you some my> personal views on the same. this is an entire> persoinal views. > > When i was studing pharmacology in second year, i> taught , how drugs works, kinetics

and dtynamicsI> taught how to make LASOTIYAs...mixtures of various> preparations.....and when i grew up , in third year> i taught that what ever you learned in pharmacology> is entirly theory and we the clinicians are dealing> with the patients and not the disease describe in> the text.> > Why thre are so much controversiers eventhough the> pharmacology and medicines are same??> > After many years of thinking on this topic i can> come to know little what are the roots of these> controversies!!> > 1) what we studied was use less in terms of> clinical setting. when ample no of pharmaceuticlas> are making remedies for each illness then why should> we waste our time behind so called> lasotiyas........thanks to some working teachers ,> now these portion has been removed from curriculum.> > 2) we used to

remember the pharmacokinetics,> dynamics and uses of penicilline V.......the drug i> never come across after second year!! why are we> learning useless thigs?> > 3) we used to mug up the uses of various> antibiotics.....but dont know which drug is to be> administered in sore throat? cant we teach clinical> pharmacology?? instead of drugs in disease...cant> we teach disease and their drugs?> > 4) Lack of interaction between pharmacologist and> clinicians.........instead of talking what clinician> should do and dont, cant we unit and make some> protocol??> > 5) when i started practice as consultant physician> in village, i faced many problems....because.....THE> CONCEPT OF THERE IS PILL FOR EVERY ILL by so called> DOCTORS..BAMS, DHMS and waht not?? what to do in> this circumstances?? i took three months to

change> senarios in the village by conducting many lectures> and health promotional events.........who will do> all these?? it is better to prescribe a pill than> three months of perspiration!!> > 6) we derpend on western literature entirly. for> example.........malaria eventhough, india harbours> 40% of worlds malarial cases.....we have to follow> the guidelines of WHO.....made by the persons who is> not in the field and based on the analysis of> studies published in reputed journals because we> believe in evidence based medicine!!> > none of the text describes.......what to do when> you come across a patient> who has clinical features resembling malaria but> either you dnt have facility for PS examination or> trained staff who can see parasite?? Many are dying> of malaria, TB, and other infectious disease than>

CAD but everyone is behind statins!!!> > 7) education of patient is also a hurdle behind> rational practice...........in that matter you have> to be irrational to practice rationally!!.> > > there are many still points........we will not> discuss what are the problems beacuse we all> know.......i will not suggest who should do and who> dnt..........because everyone knows what he/she can> do and contribute........so i will leave this upon> everybody ...............> > > Thanks,> > Dr. Viral Shah> > > > > ---------------------------------> Now you can chat without downloading messenger.> Click here to know how.__________________________________________________________Looking for last minute shopping deals? Find them fast

with Search. http://tools.search./newsearch/category.php?category=shopping

Looking for last minute shopping deals? Find them fast with Search.

[Guest guest]

Dear Dr Viral and Dr Gajjar, I agree with you that pharma teaching and learning in 2nd year simply looks like theory. However as we start clinical practice, we understand the importance of pharmacology. Instead of simple didatic lectures, we could make things interesting by case based learning. Anupama.Bharat Gajjar <gajjarbm@...> wrote: Dear Dr.Viral Shah,Thank you for your experienced opinion on Pharmacologyteaching.-Now most of the colleges have discontinued teachingof

dispensing pharmacy.Instead we are teachingclinical pharmacy.-We,at our college,P.S.MedicalCollege,Karamsad,Gujarat give more stress on clinicalpharmacology.Disease to drug concept is adopted by usthrough integrated teaching.-We,pharmacologists are constantly keeping in touchwith clinicians,undertaking projects based on patientcare with collaboration with them.-We are teaching our students the principles ofessential drugs,Rational Drug Therapy,Adverse DrugReaction Monitoring etc. to make them efficient firstcontact doctor.With regards,Dr.Bharat Gajjar.Associate Professor,Department of Pharmacology,P.S.Medical College,Karamsad,Gujarat.--- "Dr.viral shah" <viralshah_rational (DOT) co.in>wrote:> Dear NETRUM members,> > Though i am not a regular and sincere member, i> would

like to share some of my personal views on the> rationality in practicle.> > Since, many days, i am reading very good articles> by eminent personalities in the field of> pharmacology and others. I really enjoyed> pharmacogenemics, antimocrobial usage and rational> investigation approach.> > Being practitioner, i can tell you some my> personal views on the same. this is an entire> persoinal views. > > When i was studing pharmacology in second year, i> taught , how drugs works, kinetics and dtynamicsI> taught how to make LASOTIYAs...mixtures of various> preparations.....and when i grew up , in third year> i taught that what ever you learned in pharmacology> is entirly theory and we the clinicians are dealing> with the patients and not the disease describe in> the text.> > Why thre are so much controversiers

eventhough the> pharmacology and medicines are same??> > After many years of thinking on this topic i can> come to know little what are the roots of these> controversies!!> > 1) what we studied was use less in terms of> clinical setting. when ample no of pharmaceuticlas> are making remedies for each illness then why should> we waste our time behind so called> lasotiyas........thanks to some working teachers ,> now these portion has been removed from curriculum.> > 2) we used to remember the pharmacokinetics,> dynamics and uses of penicilline V.......the drug i> never come across after second year!! why are we> learning useless thigs?> > 3) we used to mug up the uses of various> antibiotics.....but dont know which drug is to be> administered in sore throat? cant we teach clinical> pharmacology?? instead

of drugs in disease...cant> we teach disease and their drugs?> > 4) Lack of interaction between pharmacologist and> clinicians.........instead of talking what clinician> should do and dont, cant we unit and make some> protocol??> > 5) when i started practice as consultant physician> in village, i faced many problems....because.....THE> CONCEPT OF THERE IS PILL FOR EVERY ILL by so called> DOCTORS..BAMS, DHMS and waht not?? what to do in> this circumstances?? i took three months to change> senarios in the village by conducting many lectures> and health promotional events.........who will do> all these?? it is better to prescribe a pill than> three months of perspiration!!> > 6) we derpend on western literature entirly. for> example.........malaria eventhough, india harbours> 40% of worlds malarial

cases.....we have to follow> the guidelines of WHO.....made by the persons who is> not in the field and based on the analysis of> studies published in reputed journals because we> believe in evidence based medicine!!> > none of the text describes.......what to do when> you come across a patient> who has clinical features resembling malaria but> either you dnt have facility for PS examination or> trained staff who can see parasite?? Many are dying> of malaria, TB, and other infectious disease than> CAD but everyone is behind statins!!!> > 7) education of patient is also a hurdle behind> rational practice...........in that matter you have> to be irrational to practice rationally!!.> > > there are many still points........we will not> discuss what are the problems beacuse we all> know.......i will not suggest

who should do and who> dnt..........because everyone knows what he/she can> do and contribute........so i will leave this upon> everybody ...............> > > Thanks,> > Dr. Viral Shah> > > > > ---------------------------------> Now you can chat without downloading messenger.> Click here to know how.__________________________________________________________Looking for last minute shopping deals? Find them fast with Search. http://tools.search./newsearch/category.php?category=shopping

Save all your chat conversations. Find them online.

[Guest guest]

Dear member, thank you Dr. anupama and Dr. Bharat Gajjar. I know that there are lots of changes being made in the pharmacology teaching. Thanks to all teachers like you. I know about the department of Pharmacology of Karamsad since time of Dr. Sagun Sir. Thanks to all eminent teachers like Sagun sir, Dr. B.K.Shah, Dr. Buch Sir, Dr. Dixit sir and many more from whom i learnt what the rationality is. For me the role of a teacher is not simply to teach only but to transform a student to real doctor ( L. Docere means to teach). Again, i am sorry for anguish letter which was not meant to hurt anyone. thank,. Viral shah Dear Dr.Viral Shah,Thank you for your experienced opinion on Pharmacologyteaching.-Now most of the colleges have discontinued teachingof dispensing pharmacy.Instead we are teachingclinical pharmacy.-We,at our college,P.S.MedicalCollege,Karamsad,Gujarat give more stress on clinicalpharmacology.Disease to drug concept is adopted by usthrough integrated teaching.-We,pharmacologists are constantly keeping in touchwith clinicians,undertaking projects based on patientcare with collaboration with them.-We are teaching our students the principles ofessential drugs,Rational Drug Therapy,Adverse DrugReaction Monitoring etc. to make them efficient firstcontact doctor.With regards,Dr.Bharat

Gajjar.Associate Professor,Department of Pharmacology,P.S.Medical College,Karamsad,Gujarat.--- "Dr.viral shah" <viralshah_rational (DOT) co.in>wrote:> Dear NETRUM members,> > Though i am not a regular and sincere member, i> would like to share some of my personal views on the> rationality in practicle.> > Since, many days, i am reading very good articles> by eminent personalities in the field of> pharmacology and others. I really enjoyed> pharmacogenemics, antimocrobial usage and rational> investigation approach.> > Being practitioner, i can tell you some my> personal views on the same. this is an entire> persoinal views. > > When i was studing pharmacology in second year, i> taught , how drugs works, kinetics and dtynamicsI> taught how to

make LASOTIYAs...mixtures of various> preparations.....and when i grew up , in third year> i taught that what ever you learned in pharmacology> is entirly theory and we the clinicians are dealing> with the patients and not the disease describe in> the text.> > Why thre are so much controversiers eventhough the> pharmacology and medicines are same??> > After many years of thinking on this topic i can> come to know little what are the roots of these> controversies!!> > 1) what we studied was use less in terms of> clinical setting. when ample no of pharmaceuticlas> are making remedies for each illness then why should> we waste our time behind so called> lasotiyas........thanks to some working teachers ,> now these portion has been removed from curriculum.> > 2) we used to remember the pharmacokinetics,>

dynamics and uses of penicilline V.......the drug i> never come across after second year!! why are we> learning useless thigs?> > 3) we used to mug up the uses of various> antibiotics.....but dont know which drug is to be> administered in sore throat? cant we teach clinical> pharmacology?? instead of drugs in disease...cant> we teach disease and their drugs?> > 4) Lack of interaction between pharmacologist and> clinicians.........instead of talking what clinician> should do and dont, cant we unit and make some> protocol??> > 5) when i started practice as consultant physician> in village, i faced many problems....because.....THE> CONCEPT OF THERE IS PILL FOR EVERY ILL by so called> DOCTORS..BAMS, DHMS and waht not?? what to do in> this circumstances?? i took three months to change> senarios in the village

by conducting many lectures> and health promotional events.........who will do> all these?? it is better to prescribe a pill than> three months of perspiration!!> > 6) we derpend on western literature entirly. for> example.........malaria eventhough, india harbours> 40% of worlds malarial cases.....we have to follow> the guidelines of WHO.....made by the persons who is> not in the field and based on the analysis of> studies published in reputed journals because we> believe in evidence based medicine!!> > none of the text describes.......what to do when> you come across a patient> who has clinical features resembling malaria but> either you dnt have facility for PS examination or> trained staff who can see parasite?? Many are dying> of malaria, TB, and other infectious disease than> CAD but everyone is behind

statins!!!> > 7) education of patient is also a hurdle behind> rational practice...........in that matter you have> to be irrational to practice rationally!!.> > > there are many still points........we will not> discuss what are the problems beacuse we all> know.......i will not suggest who should do and who> dnt..........because everyone knows what he/she can> do and contribute........so i will leave this upon> everybody ...............> > > Thanks,> > Dr. Viral Shah> > > > > ---------------------------------> Now you can chat without downloading messenger.> Click here to know how.__________________________________________________________Looking for last minute shopping deals? Find them fast with Search. http://tools.search./newsearch/category.php?category=shopping

Chat on a cool, new interface. No download required. Click here.

[Guest guest]

Hi Viral

None is hurt. Keep writing. Individual expressions help others

learn. That is why networking exists and we throb.Cheers!

Vijay

>

> > Dear NETRUM members,

> >

> > Though i am not a regular and sincere member, i

> > would like to share some of my personal views on the

> > rationality in practicle.

> >

> > Since, many days, i am reading very good articles

> > by eminent personalities in the field of

> > pharmacology and others. I really enjoyed

> > pharmacogenemics, antimocrobial usage and rational

> > investigation approach.

> >

> > Being practitioner, i can tell you some my

> > personal views on the same. this is an entire

> > persoinal views.

> >

> > When i was studing pharmacology in second year, i

> > taught , how drugs works, kinetics and dtynamicsI

> > taught how to make LASOTIYAs...mixtures of various

> > preparations.....and when i grew up , in third year

> > i taught that what ever you learned in pharmacology

> > is entirly theory and we the clinicians are dealing

> > with the patients and not the disease describe in

> > the text.

> >

> > Why thre are so much controversiers eventhough the

> > pharmacology and medicines are same??

> >

> > After many years of thinking on this topic i can

> > come to know little what are the roots of these

> > controversies!!

> >

> > 1) what we studied was use less in terms of

> > clinical setting. when ample no of pharmaceuticlas

> > are making remedies for each illness then why should

> > we waste our time behind so called

> > lasotiyas........thanks to some working teachers ,

> > now these portion has been removed from curriculum.

> >

> > 2) we used to remember the pharmacokinetics,

> > dynamics and uses of penicilline V.......the drug i

> > never come across after second year!! why are we

> > learning useless thigs?

> >

> > 3) we used to mug up the uses of various

> > antibiotics.....but dont know which drug is to be

> > administered in sore throat? cant we teach clinical

> > pharmacology?? instead of drugs in disease...cant

> > we teach disease and their drugs?

> >

> > 4) Lack of interaction between pharmacologist and

> > clinicians.........instead of talking what clinician

> > should do and dont, cant we unit and make some

> > protocol??

> >

> > 5) when i started practice as consultant physician

> > in village, i faced many problems....because.....THE

> > CONCEPT OF THERE IS PILL FOR EVERY ILL by so called

> > DOCTORS..BAMS, DHMS and waht not?? what to do in

> > this circumstances?? i took three months to change

> > senarios in the village by conducting many lectures

> > and health promotional events.........who will do

> > all these?? it is better to prescribe a pill than

> > three months of perspiration!!

> >

> > 6) we derpend on western literature entirly. for

> > example.........malaria eventhough, india harbours

> > 40% of worlds malarial cases.....we have to follow

> > the guidelines of WHO.....made by the persons who is

> > not in the field and based on the analysis of

> > studies published in reputed journals because we

> > believe in evidence based medicine!!

> >

> > none of the text describes.......what to do when

> > you come across a patient

> > who has clinical features resembling malaria but

> > either you dnt have facility for PS examination or

> > trained staff who can see parasite?? Many are dying

> > of malaria, TB, and other infectious disease than

> > CAD but everyone is behind statins!!!

> >

> > 7) education of patient is also a hurdle behind

> > rational practice...........in that matter you have

> > to be irrational to practice rationally!!.

> >

> >

> > there are many still points........we will not

> > discuss what are the problems beacuse we all

> > know.......i will not suggest who should do and who

> > dnt..........because everyone knows what he/she can

> > do and contribute........so i will leave this upon

> > everybody ...............

> >

> >

> > Thanks,

> >

> > Dr. Viral Shah

> >

> >

> >

> >

> > ---------------------------------

> > Now you can chat without downloading messenger.

> > Click here to know how.

>

> __________________________________________________________

> Looking for last minute shopping deals?

> Find them fast with Search.

http://tools.search./newsearch/category.php?

category=shopping

>

>

>

>

>

> ---------------------------------

> Chat on a cool, new interface. No download required. Click here.

>